Concentra Raised Guidance and Quietly Retired Its AI-Buildout Story

Q3 revenue rose 8.6% and EBITDA 17.9% as a new CEO took the chair — but the reshoring and data-center tailwind management spent a year selling is suddenly 'immaterial,' and the tape agrees.

CON · Earnings Call · 2026-11-06

A handoff into a very good quarter

Concentra's November 1 leadership transition — Matthew DiCanio to CEO, Tanner Newton to CFO, Keith Newton to Executive Chairman — arrived on top of the best quarter in the company's short public life. Revenue came in at $622.1M, up 8.6% year over year; adjusted EBITDA $140.2M, up 17.9%; margin 22.5%, up 178 basis points; adjusted EPS $0.52, up 33%. Management raised the top and bottom of the 2026 revenue range to $2.36–$2.38B and EBITDA to $505–$510M. Free cash flow guidance of $220–240M and capex of $70–80M were left untouched. The stock has already voted. CON is up 32.3% over the last 90 trading days and 87.8% since its 2024 listing, sitting within 3% of an all-time high of $43.56 set two days before the print. That is not a beaten-down name delivering an in-line quarter; that is a re-rating, and re-ratings invite scrutiny of the story underneath. Total revenue is up 22% over three years, but the multiple has moved faster: price-to-revenue has gone from 1.28x a year ago to 1.66x.

The one-quarter problem

Buried in the segment detail is the number that matters most. Employer services visits per day rose 5.8% year over year, against a business that had been grinding along at 1–2%. That is the highest-frequency read Concentra has on blue-collar hiring, because drug screens and pre-employment physicals sit at the front of the labor cycle — ahead of the injuries that drive the far more lucrative workers' comp business, which grew visits 4.2%. In prior calls, Chairman Keith Newton made the linkage explicit: “Employer Services is a leading indicator that ultimately yields or comp” — William Newton, Chief Executive Officer · 2026-08-07. So why did the CEO spend his answer sandbagging it? “We have historically seen when there is a pickup in employer services, there is a subsequent pickup in work comp. What I would say here is it is 1 quarter of data.” — Matthew T. DiCanio, President and Chief Executive Officer · 2026-11-06 The drug screens and physicals strength was broad — transportation and logistics, manufacturing, construction — but the company has been burned before. Employer services growth was "trending in the 1% to 2% growth rate range" for quarters, and Newton notes 40–45 years of visit data have repeatedly shown false dawns. What is not disputable is the duration of the current run. “We have obviously had 5, 6 quarters here where our visits are above that long term algorithm.” — Matthew T. DiCanio, President and Chief Executive Officer · 2026-11-06 Total visits averaged more than 58,000 per day; growth was broad across all six regions and most end markets. The share gains keyword topped the company's theme list this quarter — a promotion from the prior quarter's second-tier placement — and management attributes it to retention at multiyear highs and new business tracking ahead of 2025 levels.

The story management stopped selling

Here is the real change. For four quarters, Concentra's pitch included an emerging industrial tailwind: onshoring, manufacturing reshoring, and the AI data-center build. A year ago the message was unalloyed enthusiasm — “Every day, you hear additional proposed investment back in the United States with all the reshoring efforts that are going across the country. So every time we see an update like that, it's exciting for our business.” — Matthew DiCanio, President and Chief Financial Officer · 2025-08-08 Two quarters ago, that had hardened into claimed evidence: Texas and Oklahoma construction markets were named, with the CEO saying “we definitely are seeing early signs of it.” — Matthew DiCanio, President and Chief Executive Officer · 2026-08-07 On this call the same executive poured cold water on it.

With respect to data centers, it is a really small ... it is a growing part of our business, but it is still relatively small and immaterial part of the overall book of business. ... On the overall reshoring trend ... it is still a little bit too early to definitively say that one way or the other.
Tanner Newton, Chief Financial Officer · 2026-11-06

That is a careful, deliberate deflation of a narrative — and the keyword data confirms management's mouth and its editorial footprint moved together. Data center was the company's second-ranked theme in the June quarter. It does not appear anywhere in the top thirty this quarter. What survives is the softer reshoring trends, now wrapped in caveats. Analysts still asked about it — twice — and about the election results; the answer was that demand is broad-based across geographies and industries and the company has "no view" on the political backdrop. The candour cuts both ways. Concentra is tracking 300-plus projects through its on-site and brick-and-mortar sales forces, which is real pipeline, but the tape has already marked the theme down: the market's AI data-center basket is roughly 29% lower over 90 days and 25% lower over 30, with dozens of decliners. Management is not fighting that wave; it is quietly stepping off it.

Growth now comes from pins on a map

With the macro narrative shelved, the growth maths rest on the boring, repeatable stuff. Four Minnesota medical centers were acquired in the quarter; three De Novo centers opened in Kansas City, Boise and Daytona Beach, with two more after quarter-end and one to come, for 15 new centers in 2026 and low-double-digit openings planned for 2027. The ramp playbook is the underrated part of the story: a national sales force lands large corporates first — Keith Newton's description of walking in the local UPS, Amazon or FedEx terminal and converting those anchor accounts inside a five-to-ten-minute drive time — which is why new centers can open at 25 to 50 visits a day in week one and pay back in two to three years including capital. New York remains the dangling option. “We got through the public comment period. The regulator basically said, hey. Take your comments. Understand them, but we are going to stick with our existing proposal for now.” — Tanner Newton, Chief Financial Officer · 2026-11-06 Entry, if it comes, is a 2027 event via de novo or small bolt-ons. The real near-term catalyst is the fee schedule window: 20 to 25 states publish next year's workers' comp rates in the next 45 to 60 days, mostly effective January 1.

Margins: from expansion to defence

The income statement was excellent; the forward language was not. Cost of services fell to 68.6% of revenue from 70.8% on staffing efficiency, but adjusted G&A ticked up to 9.1% of revenue from 8.5%, and the CFO guided the run rate to something between the second and third quarters. Then the key line: “Would I expect to see the same level of margin expansion year over year that we saw in 2026 relative to 2025. Probably not. But I do think that we can sustain the current level of margin going forward.” — Tanner Newton, Chief Financial Officer · 2026-11-06 Operating margin has already done the hard work; the debate shifts to durability. Cash is the one soft spot. Operating cash flow fell to $51.9M from $60.6M, and free cash flow to $32.2M from $40.2M, on working capital timing and the roll-off of certain tax benefits tied to the OBBBA. Free cash flow less stock comp has still improved materially across the last three years, and the full-year guide was held, not cut.

The balance sheet becomes the flywheel

At 2.9x net leverage, with S&P lifting the corporate rating to BB and Moody's moving its outlook to positive, the capital allocation hierarchy has shifted. A new $250M repurchase authorization replaced a nearly exhausted $100M program; $34.65M of stock was retired in the quarter plus $8M of dividends. “Now that we are below 3x leverage and working down towards 2.5x, we are able to elevate share repurchases into the category of 1b, 1c alongside debt pay down.” — Tanner Newton, Chief Financial Officer · 2026-11-06 Effective net cash is still deeply negative at −$1.4B but is moving the right way, and price to net income of 18.5x is the market's price for that de-levering plus the 8–9% top line. The honest read: this was a genuinely strong quarter in which management chose to shrink its ambitions on narrative, not on numbers. The visit volume cycle is real (five or six quarters of it), the de novo machine is compounding, and the balance sheet is free. But the next leg of the re-rating needs the employer-services acceleration to last more than one quarter of data — and the fees that will confirm 2027 pricing land in the next six weeks.